Committee debates narrower vs. broader language on fentanyl analogs; sponsors to draft fix

Representative Reed introduced House Bill 234 on Feb. 17 to update the statutory definition of fentanyl for criminal sentencing to include fentanyl‑related substances, analogs and specified compounds. Katerina Babcock, the forensic lab director, testified that roughly 40 percent of the lab’s cases are fentanyl‑related and emphasized prosecutorial clarity when lab reports are presented in court.

Supporters including law‑enforcement officials and business representatives asked for clearer statutory language so prosecutors and juries can identify fentanyl‑type substances in cases. "We are seeing about 40 percent of our cases being fentanyl," said Katerina Babcock, noting the lab’s need to specify commonly encountered analogs.

Committee members and legal staff debated whether to (1) list specific analogs seen by the lab, (2) rely on the criminal code’s existing definition of 'controlled substance analog,' or (3) cross‑reference the Controlled Substances Act (30‑31‑2(u)). Concerns focused on potential overbreadth, inconsistent statutory terms ("chemically similar" vs. "substantially similar") and the risk of creating vagueness that courts could overturn.

Members proposed drafting language that would incorporate the Controlled Substances Act definition but keep the enhancement limited to fentanyl analogs. The sponsor agreed to work with staff and bring a drafted amendment to the committee the following day rather than finish action during the session.

No final vote occurred; the chair scheduled an amendment and the bill will return for further consideration.